India grants approval for its first nasal spray.

CREDIT TO GOOGLE

CREDIT TO GOOGLE

Recently, the COVID-19 fight has thrust non-injectable vaccination technologies in the spotlight.

CREDIT TO GOOGLE

Tuesday saw the first nasal spray vaccination in India receive approval from the pharma authority.

CREDIT TO GOOGLE

A large step in the direction of expanding the global accessibility of the newly popular needle-free vaccines.

CREDIT TO GOOGLE

Bharat Biotech, a manufacturer of the injectable COVAXIN Covid-19 vaccine in India, created the nasal vaccine.

CREDIT TO GOOGLE

The nasal spray vaccination was created in collaboration between Bharat Biotech and Washington University in St. Louis in the United States.

CREDIT TO GOOGLE

Adenovirus vector vaccine technology, similar to that used in COVID-19 vaccinations, is employed in the vaccine known as iNCOVACC to elicit an immunological response.

CREDIT TO GOOGLE

Bharat Biotech Chairman Krishna Ella hailed the clearance of his company's new vaccine as a "global game changer" for the advancement of intranasal vaccine technology.

CREDIT TO GOOGLE

The major development in intranasal vaccine technology for the pandemic so far has been the Indian government's clearance of Bharat Biotech's nasal spray.